Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 December 2021 | Story Xolisa Mnukwa | Photo Supplied
Former UFS 2020/2021 Student Representative Council (SRC) member, Michael Mnguni describes the journey he travelled towards obtaining his BA in Governance and Political Transformation in 2021.

“I have travelled a long journey, from receiving my acceptance letter back in February 2017 after applying late, to obtaining a BA in Governance and Political Transformation in 2021. 

“I am the child of a single mother who worked as a domestic worker and resigned after I obtained my qualification. Her employer provided us with R10 000 to travel to Bloemfontein in 2017 – a day before registration was supposed to close – to pay for registration, which was about R6 000 at that time.” 

This is how UFS and former Student Representative Council (SRC) member, Michael Mgnuni, describes his journey from destitute student to SRC member and eventually UFS graduate.  

Mguni, who served on the 2020/2021 Bloemfontein Campus SRC responsible for the portfolio: Associations Student Council, said the hardships he faced instilled a desire for continuous improvement. 

“I did not have any form of funding, and back home no one thought I would make it to university because I did not get admitted to other institutions. I am a first-generation student and the firstborn in my family. The past five years have not been easy; especially when you are living far from home, you have to be independent and aware of what is happening in your surroundings.”

On 10 December 2021, Mgnuni became one of the hundreds of graduates who received their qualifications during the UFS virtual graduation ceremonies, obtaining a Bachelor of Arts in Governance and Political Transformation. 

“To obtain this qualification, I would go many days without food and study on an empty stomach. I was dealing with my own mental-health issues while attending to the well-being of others around me, because they became my brothers and sisters.” 

“My graduation journey was not easy; for the first four months at varsity, I travelled from Phahameng to school – living in my aunt’s back room. I had no funding, but my mother would send me money from the little she had, to ensure that I didn’t go to bed on an empty stomach. Through it all, I have conquered. My experiences inspired me to become a student activist, because I didn’t want prospective and returning UFS students to experience the same struggles I went through.” 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept